Radio and PodcastLive Radio & Podcasts

Search Radio and Podcast

Podcasts›Biotech 2050 Podcast›Foresite Capital’s Jim Tananbaum on Biotech Cycles, AI Breakthroughs & Long-Term Value

Science & Medicine

Foresite Capital’s Jim Tananbaum on Biotech Cycles, AI Breakthroughs & Long-Term Value

Biotech 2050 Podcast by Biotech2050 Podcast

Nov 5, 202500:23:17Science & Medicine

Synopsis: Jim Tananbaum, Founder & CEO of Foresite Capital, joins Rahul Chaturvedi to dissect the patterns driving biotech innovation, the role of macroeconomic cycles in venture performance, and how disciplined science...

Related Episodes

Continue listening to more episodes from Biotech 2050 Podcast.

Nick Myerberg, Partner & Head of AI at Braidwell on AI's Next Era in Drug Discovery

Aug 3, 2026 - 00:47:40

Synopsis: The guest on today's podcast is a representative of Braidwell LP, a registered investment advis...

Robert Jacks, CEO of Sparrow Pharmaceuticals Precision Medicine, Biotech Strategy & Leadership

Jul 22, 2026 - 00:34:19

Synopsis: In an industry often defined by rapid innovation and high-stakes science, long-term success in...

Ardelyx Leaders Mike Raab & Laura Williams on Building Biotech Around Patients

Jun 10, 2026 - 00:41:21

Synopsis: While biotech is increasingly measured by clinical milestones and financial outcomes, Rahul Cha...

Acadia CEO Catherine Owen Adams on Neurodegeneration, AI & Building Biotech Vision

May 13, 2026 - 00:33:34

Synopsis: At the intersection of personal mission and biotech leadership, Rahul Chaturvedi sits down with...

Barry Quart, CEO of Connect Biopharma, on Asthma Innovation & Biotech Leadership

Apr 16, 2026 - 00:23:07

Synopsis: This episode is proudly sponsored by Quartzy. At a time when biotech innovation is being reshap...

Adial CEO Cary Claiborne on Treating Alcohol Addiction with Genetics

Mar 6, 2026 - 00:14:16

Synopsis: Addiction is often misunderstood as a failure of willpower—but emerging science increasingly sh...

Sheila Gujrathi, MD on Leadership, Biotech Innovation & The Mirror Effect for Women Leaders

Mar 5, 2026 - 00:39:59

Synopsis: This episode is proudly sponsored by Quartzy. Physician-scientist, biotech founder, and leaders...

Fred Aslan, Artiva CEO, on Cell Therapy’s Next Wave, RA Trials & Scalable NK Platforms

Feb 11, 2026 - 00:25:06

Synopsis: At the heart of JPM 2026’s biotech buzz, Alok Tayi sits down with Fred Aslan, CEO of Artiva, to...